September 21st 2023
press releases
September 5th 2023
press releases
August 1st 2023
press releases
Upcoming Events
Whats next.
September 26th 2023 - September 28th 2023
read more
October 20th 2023 - October 24th 2023
read more
passion.
It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research is the strong foundation for developing potential in effective treatment.
What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.
